Tech Company Financing Transactions
Eyestem Research Funding Round
Private investors participated in a $10 million venture round for Eyestem Research. The round was announced on 8/11/2025.
Transaction Overview
Company Name
Announced On
8/11/2025
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The proceeds will be directed towards completing the ongoing Phase 2 clinical trial of its retinal pigment epithelial cell therapy, Eyecyte-RPE�, in India and preparing for an Investigational New Drug application with the United States Food and Drug Administration.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Centre for Cellular And Molecular Platforms (C-CAMP), NCBS-T
Bengaluru, Karnataka, 560065
India
Bengaluru, Karnataka, 560065
India
Phone
Undisclosed
Website
Email Address
Overview
Eyestem is a cell therapy company founded by a top-class management team consisting of clinical trial, cell therapy and ophthalmology experts. It also boasts a world class advisory board and has built collaborations with pioneers and leaders in the space. Our long-term vision is to create a scalable cell therapy platform to treat incurable diseases and democratize access to these newer technologies for the bottom 99 % of the population globally.
Management Team
Browse more venture capital transactions:
Prev: 8/9/2025: Alkymi venture capital transaction
Next: 8/11/2025: Graas.ai venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs